Tnfrsf11b (Mouse) ELISA Kit
* The price is valid only in USA. Please select country.
-
More Files
- More Functions
-
Specification
Product Description
Tnfrsf11b (Mouse) ELISA Kit is a sandwich enzyme immunoassay for the quantitative measurement of mouse Tnfrsf11b.
Suitable Sample
Body Fluid, Cell Culture Supernatant, Plasma, Serum, Tissue Lysate
Sample Volume
100 uL
Label
HRP-conjugated
Detection Method
Colorimetric
Assay Type
Quantitative
Calibration Range
93.8 to 6000 pg/mL
Reactivity
Mouse
Regulation Status
For research use only (RUO)
Quality Control Testing
Standard curve
The standard curve is for the purpose of illustration only and should not be used to calculate unknowns. A standard curve should be generated each time the assay is performed.
Storage Instruction
Store at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles.
-
Applications
Quantification
-
Gene Info — Tnfrsf11b
-
Publication Reference
-
Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
Tudpor K, van der Eerden BC, Jongwattanapisan P, Roelofs JJ, van Leeuwen JP, Bindels RJ, Hoenderop JG.
Bone 2015 Mar; 72:14.
Application:ELISA, Mouse, Serum.
-
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease.
Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J.
Circulation 2004 May; 109(18):2175.
Application:Quant, Human, Human blood.
-
Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis.
Ohmori H, Makita Y, Funamizu M, Hirooka K, Hosoi T, Orimo H, Suzuki T, Ikari K, Nakajima T, Inoue I, Hata A.
Journal of Human Genetics 2002 Aug; 47(8):400.
-
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.
Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K.
Endocrinology 1998 Mar; 139(3):1329.
-
Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
- +1-909-264-1399
+1-909-992-0619
Toll Free : +1-877-853-6098 - +1-909-992-3401
- sales@abnova.com